NASDAQ:NXGN NextGen Healthcare (NXGN) Stock Forecast, Price & News $16.26 +0.02 (+0.12%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$16.22▼$16.7150-Day Range$15.35▼$18.0652-Week Range$15.23▼$21.99Volume306,305 shsAverage Volume439,853 shsMarket Capitalization$1.07 billionP/E RatioN/ADividend YieldN/APrice Target$21.20 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media NextGen Healthcare MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside30.4% Upside$21.20 Price TargetShort InterestBearish6.63% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.31Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth33.33%From $0.66 to $0.88 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.19 out of 5 starsMedical Sector340th out of 987 stocksComputer Integrated Systems Design Industry17th out of 33 stocks 3.3 Analyst's Opinion Consensus RatingNextGen Healthcare has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $21.20, NextGen Healthcare has a forecasted upside of 30.4% from its current price of $16.26.Amount of Analyst CoverageNextGen Healthcare has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted6.63% of the float of NextGen Healthcare has been sold short.Short Interest Ratio / Days to CoverNextGen Healthcare has a short interest ratio ("days to cover") of 9.7.Change versus previous monthShort interest in NextGen Healthcare has recently increased by 0.57%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldNextGen Healthcare does not currently pay a dividend.Dividend GrowthNextGen Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NXGN. Previous Next 3.5 News and Social Media Coverage News SentimentNextGen Healthcare has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for NextGen Healthcare this week, compared to 4 articles on an average week.Search Interest4 people have searched for NXGN on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NextGen Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.50% of the stock of NextGen Healthcare is held by insiders.Percentage Held by Institutions73.70% of the stock of NextGen Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for NextGen Healthcare are expected to grow by 33.33% in the coming year, from $0.66 to $0.88 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of NextGen Healthcare is -406.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NextGen Healthcare is -406.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNextGen Healthcare has a P/B Ratio of 2.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About NextGen Healthcare (NASDAQ:NXGN) StockNextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.Read More Receive NXGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NextGen Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address NXGN Stock News HeadlinesJune 3, 2023 | americanbankingnews.comNextGen Healthcare, Inc. Forecasted to Earn FY2026 Earnings of $1.05 Per Share (NASDAQ:NXGN)June 2, 2023 | americanbankingnews.comZacks Research Weighs in on NextGen Healthcare, Inc.'s Q1 2024 Earnings (NASDAQ:NXGN)June 10, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!May 27, 2023 | americanbankingnews.comNextGen Healthcare (NASDAQ:NXGN) Updates FY 2024 Earnings GuidanceMay 25, 2023 | americanbankingnews.comNextGen Healthcare (NASDAQ:NXGN) Price Target Cut to $22.00 by Analysts at GuggenheimMay 24, 2023 | americanbankingnews.comNextGen Healthcare (NASDAQ:NXGN) Price Target Cut to $18.00May 23, 2023 | markets.businessinsider.comJ.P. Morgan Reaffirms Their Sell Rating on NextGen Healthcare (NXGN)May 23, 2023 | msn.comGuggenheim Maintains NextGen Healthcare (NXGN) Buy RecommendationJune 10, 2023 | Behind the Markets (Ad)66,000% upside on tiny biotech?The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.May 23, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for NextGen HealthcareMay 22, 2023 | msn.comTruist Securities Maintains NextGen Healthcare (NXGN) Hold RecommendationMay 21, 2023 | americanbankingnews.comNextGen Healthcare (NASDAQ:NXGN) Receives New Coverage from Analysts at StockNews.comMay 21, 2023 | americanbankingnews.comPiper Sandler Cuts NextGen Healthcare (NASDAQ:NXGN) Price Target to $17.00May 21, 2023 | americanbankingnews.comNextGen Healthcare, Inc. (NASDAQ:NXGN) Given Consensus Recommendation of "Moderate Buy" by AnalystsMay 20, 2023 | fool.comNextGen Healthcare (NASDAQ: NXGN)May 18, 2023 | msn.comPiper Sandler Maintains NextGen Healthcare (NXGN) Neutral RecommendationMay 17, 2023 | msn.comStephens & Co. Reiterates NextGen Healthcare (NXGN) Overweight RecommendationMay 17, 2023 | finance.yahoo.comNextGen Healthcare, Inc. (NASDAQ:NXGN) Q4 2023 Earnings Call TranscriptMay 17, 2023 | finance.yahoo.comQ4 2023 NextGen Healthcare Inc Earnings CallMay 17, 2023 | americanbankingnews.comNextGen Healthcare (NASDAQ:NXGN) Updates FY24 Earnings GuidanceMay 16, 2023 | finance.yahoo.comNextgen Healthcare (NXGN) Q4 Earnings and Revenues Surpass EstimatesMay 16, 2023 | finance.yahoo.comNextgen Healthcare (NXGN) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesMay 16, 2023 | forbes.comHow NextGen EMR Breach Is A Wake-Up Call For Healthcare CIOsMay 15, 2023 | seekingalpha.comNextGen Healthcare Q4 2023 Earnings PreviewMay 15, 2023 | americanbankingnews.comNextGen Healthcare (NXGN) Set to Announce Earnings on TuesdayMay 13, 2023 | markets.businessinsider.comPRIVACY ALERT: NextGen Healthcare Under Investigation for Data Breach of One Million Patient RecordsMay 10, 2023 | msn.comNextGen: A Liquid Diversifier To Equity Risk, Continued Buy At 16x P/ESee More Headlines NXGN Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXGN Company Calendar Last Earnings5/16/2023Today6/10/2023Next Earnings (Estimated)7/25/2023Fiscal Year End3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Computer integrated systems design Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NXGN CUSIPN/A CIK708818 Webwww.nextgen.com Phone(949) 255-2600Fax949-255-2605Employees2,783Year FoundedN/APrice Target and Rating Average Stock Price Forecast$21.20 High Stock Price Forecast$25.00 Low Stock Price Forecast$17.00 Forecasted Upside/Downside+30.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E Ratio24.64 P/E GrowthN/ANet Income$-2,650,000.00 Net Margins-0.41% Pretax Margin0.66% Return on Equity8.51% Return on Assets4.78% Debt Debt-to-Equity Ratio0.67 Current Ratio2.03 Quick Ratio2.03 Sales & Book Value Annual Sales$653.17 million Price / Sales1.64 Cash Flow$1.17 per share Price / Cash Flow13.95 Book Value$6.07 per share Price / Book2.68Miscellaneous Outstanding Shares65,980,000Free Float63,012,000Market Cap$1.07 billion OptionableOptionable Beta1.02 Key ExecutivesDavid William SidesPresident, Chief Executive Officer & DirectorL. Allen PlunkExecutive Vice President-OperationsJames R. ArnoldChief Financial Officer & Executive Vice PresidentRobert L. MurryChief Medical OfficerDavid SlazykChief Information & Security OfficerKey CompetitorsMerusNASDAQ:MRUSOrthoPediatricsNASDAQ:KIDSKiniksa PharmaceuticalsNASDAQ:KNSAMirum PharmaceuticalsNASDAQ:MIRMScilexNASDAQ:SCLXView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Sold 19,945 shares on 5/22/2023Ownership: 0.547%Putnam Investments LLCSold 2,293 shares on 5/22/2023Ownership: 0.081%JPMorgan Chase & Co.Sold 142,154 shares on 5/18/2023Ownership: 0.421%New York State Common Retirement FundSold 171,886 shares on 5/18/2023Ownership: 0.127%Thrivent Financial for LutheransSold 3,173 shares on 5/17/2023Ownership: 0.080%View All Insider TransactionsView All Institutional Transactions NXGN Stock - Frequently Asked Questions Should I buy or sell NextGen Healthcare stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NXGN shares. View NXGN analyst ratings or view top-rated stocks. What is NextGen Healthcare's stock price forecast for 2023? 4 brokers have issued 12-month target prices for NextGen Healthcare's stock. Their NXGN share price forecasts range from $17.00 to $25.00. On average, they expect the company's share price to reach $21.20 in the next year. This suggests a possible upside of 30.4% from the stock's current price. View analysts price targets for NXGN or view top-rated stocks among Wall Street analysts. How have NXGN shares performed in 2023? NextGen Healthcare's stock was trading at $18.78 at the start of the year. Since then, NXGN shares have decreased by 13.4% and is now trading at $16.26. View the best growth stocks for 2023 here. When is NextGen Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023. View our NXGN earnings forecast. How were NextGen Healthcare's earnings last quarter? NextGen Healthcare, Inc. (NASDAQ:NXGN) announced its earnings results on Tuesday, May, 16th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The business earned $178.55 million during the quarter, compared to analysts' expectations of $170.61 million. NextGen Healthcare had a negative net margin of 0.41% and a positive trailing twelve-month return on equity of 8.51%. What ETFs hold NextGen Healthcare's stock? ETFs with the largest weight of NextGen Healthcare (NASDAQ:NXGN) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), AdvisorShares Alpha DNA Equity Sentiment ETF (SENT), Invesco S&P SmallCap Health Care ETF (PSCH), Vanguard U.S. Minimum Volatility ETF (VFMV), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), Invesco S&P SmallCap 600 Pure Growth ETF (RZG) and Royce Quant Small-Cap Quality Value ETF (SQLV). What guidance has NextGen Healthcare issued on next quarter's earnings? NextGen Healthcare updated its FY 2024 earnings guidance on Friday, May, 26th. The company provided EPS guidance of $1.04-$1.11 for the period, compared to the consensus EPS estimate of $1.10. The company issued revenue guidance of $712.00 million-$722.00 million, compared to the consensus revenue estimate of $709.32 million. What is Rusty Frantz's approval rating as NextGen Healthcare's CEO? 248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees. What other stocks do shareholders of NextGen Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR). What is NextGen Healthcare's stock symbol? NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN." Who are NextGen Healthcare's major shareholders? NextGen Healthcare's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.26%), Dimensional Fund Advisors LP (3.66%), State Street Corp (2.99%), William Blair Investment Management LLC (2.34%), Alyeska Investment Group L.P. (1.76%) and Geode Capital Management LLC (1.68%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor. View institutional ownership trends. How do I buy shares of NextGen Healthcare? Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NextGen Healthcare's stock price today? One share of NXGN stock can currently be purchased for approximately $16.26. How much money does NextGen Healthcare make? NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.07 billion and generates $653.17 million in revenue each year. The company earns $-2,650,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. How many employees does NextGen Healthcare have? The company employs 2,783 workers across the globe. How can I contact NextGen Healthcare? NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (949) 255-2600, via email at ir@nextgen.com, or via fax at 949-255-2605. This page (NASDAQ:NXGN) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NextGen Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.